The role of lipoprotein-associated phospholipase A2 on cardiovascular disease risk assessment and plaque rupture: a clinical review
Richard Batsell
Journal of Clinical Lipidology, 2009
View PDFchevron_right
Systematic Review of the Association between Lipoprotein � Associated Phospholipase A2 and Atherosclerosis
Dong Zhao
American Chinese Journal of Medicine and Science, 2011
View PDFchevron_right
Lp-PLA2—A novel marker of atherosclerosis: To treat or not to treat?
Dimitris Tousoulis, Nikolaos Papageorgiou
International Journal of Cardiology, 2013
View PDFchevron_right
Atherosclerotic Plaque Inflammation Varies Between Vascular Sites and Correlates With Response to Inhibition of Lipoprotein-Associated Phospholipase A2
D. Hamamdzic, Emile Mohler
Journal of the American Heart Association, 2015
View PDFchevron_right
Role of Lipoprotein-Associated Phospholipase A2 in Atherosclerosis: Biology, Epidemiology, and Possible Therapeutic Target
Anthony Postle
Arteriosclerosis, Thrombosis, and Vascular Biology, 2005
View PDFchevron_right
Lipoprotein-associated phospholipase A2 as a target of therapy
Colin Macphee
Current Opinion in Lipidology, 2005
View PDFchevron_right
Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development
Colin Macphee
Nature Med, 2008
View PDFchevron_right
Lipoprotein-Associated Phospholipase A2: A Promising Vascular-Specific Marker for Screening Cardiovascular Risk?
Dr. Marguerite M Engler
Progress in Cardiovascular Nursing, 2000
View PDFchevron_right
Effects of the Direct Lipoprotein-Associated Phospholipase A2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque
Michael Aschermann
Circulation, 2008
View PDFchevron_right
Group X Secreted Phospholipase A2 Limits the Development of Atherosclerosis in LDL Receptor-Null Mice
Charlotte Lahoute
Arteriosclerosis, Thrombosis, and Vascular Biology, 2013
View PDFchevron_right
Role of Lipoprotein-Associated Phospholipase A 2 in Atherosclerosis
Richard Batsell
Arteriosclerosis, Thrombosis, and Vascular Biology, 2005
View PDFchevron_right
Τhe role of lipoprotein-associated phospholipase A2 in atherosclerosis
Κωνσταντίνος Τέλλης
View PDFchevron_right
Pathophysiological Role and Clinical Significance of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Bound to LDL and HDL
Κωνσταντίνος Τέλλης
View PDFchevron_right
Role of lipoprotein-associated phospholipase A 2 in leukocyte activation and inflammatory responses
Hashim Osman
Atherosclerosis, 2007
View PDFchevron_right
Lipoprotein-associated phospholipase A2: A new therapeutic target
Eva Lonn
Canadian Journal of Cardiology, 2010
View PDFchevron_right
Lipoprotein-associated phospholipase A2: Pathogenic mechanisms and clinical utility for predicting cardiovascular events
Sanja Stankovic
Current Atherosclerosis Reports, 2006
View PDFchevron_right
The inhibition of lipoprotein-associated phospholipase A2 exerts beneficial effects against atherosclerosis in LDLR-deficient mice
Jie Li, Anthony Postle
Acta Pharmacologica Sinica, 2011
View PDFchevron_right
Lipoprotein-Associated Phospholipase A 2 Activity Predicts Progression of Subclinical Coronary Atherosclerosis
Gregory Kinney
Diabetes Technology & Therapeutics, 2011
View PDFchevron_right
Lipoprotein-Associated Phospholipase A2 Protein Expression in the Natural Progression of Human Coronary Atherosclerosis
Kristi Skorija
Arteriosclerosis Thrombosis and Vascular Biology, 2006
View PDFchevron_right
Lipoprotein-Associated Phospholipase A2 Activity Predicts Cardiovascular Events in High Risk Coronary Artery Disease Patients
Luigi Pedon
PLOS ONE, 2012
View PDFchevron_right
Lp-PLA2: A new target for statin therapy
Lynne Braun
Current atherosclerosis reports, 2010
View PDFchevron_right
Evidence Supporting a Key Role of Lp-PLA2-Generated Lysophosphatidylcholine in Human Atherosclerotic Plaque Inflammation
Mihaela Nitulescu
Arteriosclerosis, Thrombosis, and Vascular Biology, 2012
View PDFchevron_right
Randomized trial of an inhibitor of secretory phospholipase A2 on atherogenic lipoprotein subclasses in statin-treated patients with coronary heart disease
Robert Rosenson
European Heart Journal, 2011
View PDFchevron_right
Phospholipase A2 enzymes and the risk of atherosclerosis
Robert Rosenson
European Heart Journal, 2012
View PDFchevron_right
ASSESSMENT OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN CORONARY ARTERY DISEASE PATIENTS OF NORTH INDIA
International Journal of Bioassays
View PDFchevron_right
Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2
Robert Rosenson
The Journal of Lipid Research, 2012
View PDFchevron_right
Association between Lp-PLA 2 and coronary artery disease: Focus on its relationship with lipoproteins and markers of inflammation and hemostasis
Natalie Khuseyinova
Atherosclerosis, 2005
View PDFchevron_right
Lipoprotein-Associated Phospholipase A2 Is an Independent Marker for Coronary Endothelial Dysfunction in Humans
Eric Yang
2010
View PDFchevron_right